Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada Canada NewsWire HERTFORDSHIRE, England...
Mylan to Release First Quarter 2020 Financial Results on May 11, 2020 PR Newswire HERTFORDSHIRE, England and...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed...
By Kim Richters The European Commission said Wednesday that it has approved the merger between Mylan NV and Pfizer Inc.'s Upjohn division on...
Mylan Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Mylan N.V. Is...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...
false000162361300016236132020-04-152020-04-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Mylan Board Appoints Robert J. Coury As Executive Chairman of Mylan N.V. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 15, 2020...
Mylan Updates Its Efforts Regarding COVID-19 PR Newswire HERTFORDSHIRE, England and PITTSBURGH, April 8, 2020...
By Colin Kellaher Mylan N.V. and Lupin Ltd. Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use...
Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept PR Newswire HERTFORDSHIRE...
Filed by Mylan N.V. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to...
By Colin Kellaher Mylan N.V. and Pfizer Inc. on Thursday said they now expect their planned deal to combine Pfizer's off-patent drugs...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.